\n \n Other institutional investors have also adjusted their stakes in Zoetis. Brighton Jones LLC increased its holdings by 180.4% in the fourth quarter, now owning 4,629 shares valued at $754,000 after acquiring an additional 2,978 shares. Merit Financial Group LLC raised its stake by 62.3% in the first quarter, bringing its total to 12,178 shares valued at $2,005,000 after purchasing 4,676 additional shares. Romano Brothers AND Company increased its stake by 4.7%, now holding 4,096 shares valued at $674,000 after acquiring 185 more shares. Nixon Peabody Trust Co. raised its stake by 16.4%, owning 3,074 shares valued at $506,000 after acquiring 433 additional shares. Lastly, Benson Investment Management Company Inc. entered a new position in Zoetis valued at $5,310,000. Overall, institutional investors now own 92.80% of the company’s stock.\n <\/p>\n \n Zoetis has been the focus of several analyst reports recently. Stifel Nicolaus downgraded the stock from a \u201cbuy\u201d to a \u201chold\u201d rating, lowering the price target from $165.00 to $160.00 in a note dated June 18th. Similarly, Leerink Partners downgraded Zoetis from a \u201cstrong-buy\u201d to a \u201chold\u201d rating on July 17th, also reducing their price objective from $180.00 to $155.00. Conversely, Piper Sandler raised their price objective from $210.00 to $215.00, maintaining an \u201coverweight\u201d rating on August 11th. Argus reiterated a \u201cbuy\u201d rating with a price target of $190.00 on September 9th. Currently, five analysts rate the stock as a Buy, while four have given it a Hold rating. According to MarketBeat, the consensus rating for Zoetis is \u201cModerate Buy,\u201d with a consensus price target of $200.88.\n <\/p>\n View Our Latest Research Report on Zoetis<\/a><\/b><\/p>\n \n ZTS<\/a> opened at $146.87 on Thursday. The stock has a one-year low of $139.34 and a high of $196.55. Key financial ratios include a current ratio of 1.76, a quick ratio of 1.04, and a debt-to-equity ratio of 1.05. With a market cap of $65.09 billion, the company has a P\/E ratio of 25.28 and a price-to-earnings-growth ratio of 2.35, alongside a beta of 0.90. The fifty-day moving average price stands at $150.02, while the two-hundred-day moving average price is $155.39.\n <\/p>\n \n Zoetis (NYSE:ZTS<\/a> \u2013 Get Free Report<\/a>) recently announced its quarterly earnings on August 5th, reporting $1.76 earnings per share, exceeding the consensus estimate of $1.62 by $0.14. The company achieved a net margin of 27.83% and a return on equity of 56.90%, with revenues of $2.46 billion, surpassing the consensus estimate of $2.41 billion. This represents a 4.2% increase in revenue compared to the same quarter last year. For FY 2025, Zoetis has set guidance at 6.300-6.400 EPS, while analysts forecast 6.07 EPS for the current fiscal year.\n <\/p>\n (Free Report<\/a>)<\/p>\n \n Zoetis Inc. is engaged in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services both in the United States and internationally. The company focuses on a diverse range of species, including livestock such as cattle, swine, poultry, fish, and sheep, as well as companion animals like dogs, cats, and horses.\n <\/p>\n \n Want to see what other hedge funds are holding ZTS?<\/strong> Visit HoldingsChannel.com<\/a> for the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS<\/a> \u2013 Free Report<\/a>).\n <\/p>\n \n <\/p>\n <\/p>\n![\"Zoetis](\"https:\/\/www.marketbeat.com\/logos\/zoetis-inc-logo-1200x675.png?v=20221021133935\"){kind=logo}
\n Sound Income Strategies LLC has significantly increased its investment in Zoetis Inc. (NYSE:ZTS<\/a> \u2013 Free Report<\/a>) by 54.3% during the second quarter, as revealed in its latest 13F filing with the Securities and Exchange Commission (SEC). The fund now holds 432 shares of Zoetis after acquiring an additional 152 shares, bringing the total value of its holdings to approximately $67,000 at the end of the quarter.\n <\/p>\nAnalyst Upgrades and Downgrades<\/h2>\n
Zoetis Trading Up 0.4%<\/h2>\n
Zoetis Profile<\/h2>\n
See Also<\/h2>\n
\n <\/p>\n
\n
\n <\/p>\n